Showing results (161-170 of 1,579) with videos related to

Sort By:
Pageof 158
RSC Medicinal Chemistry|January 12, 2026
An overview of recent advancements in targeted cancer therapies and their potential clinical impactShujauddin Ahmed, Akash P Sakla, Kousar Jahan, et al.
RSC Medicinal Chemistry|January 12, 2026
Mitochondria-targeting symmetric diiminoguanidines: potent and selective anticancer agents against pancreatic tumorsSigrid Lacaille, Andreea R Schmitzer
RSC Medicinal Chemistry|January 19, 2026
Novel Pt@BSA nanoparticles improve radiotherapeutic outcomes in breast cancerYuhui Zhang, Yihui Liu, Dongju Zheng
RSC Medicinal Chemistry|January 7, 2026
Discovery of enaminone-linked benzofuran derivatives as dual VEGFR-2/hCA IX inhibitors exhibiting hypoxia-mediated chemosensitizationWagdy M Eldehna, Zainab M Elsayed, Mohamed R Elnagar, et al.
RSC Medicinal Chemistry|November 7, 2025
C6-Alkoxy substituted penicillins are potent non-covalently binding inhibitors of the SARS-CoV-2 main proteaseDorian-Gabriel Muntean, Wojtek Treyde, Linda Kinena, et al.
RSC Medicinal Chemistry|October 29, 2025
Isatin, a monoamine oxidase inhibitor, sensitizes resistant breast cancer cells to tamoxifen via MAO-A/HIF1α/MMPs modulationFatma M Abdelwahed, Marwa A Ibrahim, Marwa Sharaky, et al.
RSC Medicinal Chemistry|October 30, 2025
Accelerating compound synthesis in drug discovery: the role of digitalisation and automationDavid F Nippa, Alexander J Boddy, Kenneth Atz, et al.
RSC Medicinal Chemistry|October 20, 2025
Lactose-conjugated 2-iminothiazolidin-4-ones: synthesis, inhibitory activity and molecular simulations as potential inhibitors against enzymes responsible for type 2 diabetesHoang Thi Kim Van, Nguyen Dinh Thanh
RSC Medicinal Chemistry|October 20, 2025
Bacteriophage-mediated antibacterial and photodynamic therapiesRui Yu, Guo-Bo Li, Bengui Ye, et al.
RSC Medicinal Chemistry|October 6, 2025
Click synthesis of some novel benzo[d]thiazole-1,2,3-triazole hybrid compounds with benzamide and/or benzoate tethers as EGFR-dependent signaling inhibitors against breast cancerMosa Alsehli, Mohamed S Nafie, Nader R Albujuq, et al.
Pageof 158